Evidence map›Paper›PMID 34011596›Full record

ArticleBMJ open2021

Identifying the critically ill paediatric oncology patient: a study protocol for a prospective observational cohort study for validation of a modified Bedside Paediatric Early Warning System score in hospitalised paediatric oncology patients.

Marijn Soeteman, Teus H Kappen, Martine van Engelen, Ellen Kilsdonk, Erik Koomen, Edward E S Nieuwenhuis, Wim J E Tissing, Marta Fiocco, Marry van den Heuvel-Eibrink, Roelie M Wösten-van Asperen

Abstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Marijn SoetemanPrincess Máxima Center for Paediatric Oncology, Utrecht, The Netherlands.ORCID 0000-0001-6679-8965
Teus H KappenDepartment of Department of Anaesthesia, Intensive Care and Emergency, University Medical Centre Utrecht, Utrecht, The Netherlands.
Martine van EngelenPrincess Máxima Center for Paediatric Oncology, Utrecht, The Netherlands.
Ellen KilsdonkPrincess Máxima Center for Paediatric Oncology, Utrecht, The Netherlands.
Erik KoomenDepartment of Paediatric Intensive Care, University Medical Centre Utrecht/Wilhelmina Children's Hospital, Utrecht, The Netherlands.ORCID 0000-0001-7192-1227
Edward E S NieuwenhuisDepartment of Paediatrics, University Medical Centre Utrecht/Wilhelmina Children's Hospital, Utrecht, The Netherlands.
Wim J E TissingPrincess Máxima Center for Paediatric Oncology, Utrecht, The Netherlands.
Marta FioccoPrincess Máxima Center for Paediatric Oncology, Utrecht, The Netherlands.
Marry van den Heuvel-EibrinkPrincess Máxima Center for Paediatric Oncology, Utrecht, The Netherlands.
Roelie M Wösten-van AsperenDepartment of Paediatric Intensive Care, University Medical Centre Utrecht/Wilhelmina Children's Hospital, Utrecht, The Netherlands r.m.vanasperen@umcutrecht.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHospitalised paediatric oncology patients are at risk to develop acute complications. Early identification of clinical deterioration enabling adequate escalation of care remains challenging. Various Paediatric Early Warning Systems (PEWSs) have been evaluated, also in paediatric oncology patients but mostly in retrospective or case-control study designs. This study protocol encompasses the first prospective cohort with the aim of evaluating the predictive performance of a modified Bedside PEWS score for non-elective paediatric intensive care unit (PICU) admission or cardiopulmonary resuscitation in hospitalised paediatric oncology patients. METHODS AND ANALYSIS: A prospective cohort study will be conducted at the 80-bed Dutch paediatric oncology hospital, where all national paediatric oncology care has been centralised, directly connected to a shared 22-bed PICU. All patients between 1 February 2019 and 1 February 2021 admitted to the inpatient nursing wards, aged 0-18 years, with an International Classification of Diseases for Oncology (ICD-O) diagnosis of paediatric malignancy will be eligible. A Cox proportional hazard regression model will be used to estimate the association between the modified Bedside PEWS and time to non-elective PICU transfer or cardiopulmonary arrest. Predictive performance (discrimination and calibration) will be assessed internally using resampling validation. To account for multiple occurrences of the event of interest within each patient, the unit of study is a single uninterrupted ward admission (a clinical episode). ETHICS AND DISSEMINATION: The study protocol has been approved by the institutional ethical review board of our hospital (MEC protocol number 16-572/C). We adapted our enrolment procedure to General Data Protection Regulation compliance. Results will be disseminated at scientific conferences, regional educational sessions and publication in peer-reviewed journals. TRIAL REGISTRATION NUMBER: Netherlands Trial Registry (NL8957).

Indexed as

Critical IllnessNeoplasmsCase-Control StudiesChildCohort StudiesHumansIntensive Care Units, PediatricNetherlandsObservational Studies as TopicProspective StudiesRetrospective Studiespaediatric intensive & critical carepaediatric oncologyrisk management

Identifiers

PMID34011596
PMCPMC8137214

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.